Weekly News Recap #Phispers
AbbVie inks US$ 5.6 bn oncology deal with China’s RemeGen; Astra buys Modella AI to speed up cancer drug research
This week’s Phispers is packed with news from the ongoing JP Morgan Healthcare Conference (JPM26). Notably, AbbVie said i...
Impressions : 1611
Novartis inks US$ 5.2 bn cardiology deal with China’s Argo, US$ 2 bn deal with Arrowhead; FDA okays first GLP-1 generic for weight
Novartis signed two deals this week — a US$ 5.2 billion cardiology deal with China’s Argo Biopharmaceuticals, and a...
Impressions : 1233
GSK’s COPD, long-acting asthma drugs score late-stage wins; Novo’s weight-loss drug Saxenda found to be safe in kids
GSK scored a significant late-stage win with its asthma drug Nucala in treating chronic obstructive pulmonary disease (COPD). I...
Impressions : 1176
Boehringer boosts immune-oncology pipeline with US$ 1.3 bn Nerio buy; Pfizer adds US$ 1 bn to 2024 outlook
This week, the world’s largest private pharma company, Boehringer Ingelheim, acquired Nerio Therapeutics for up to US$ 1....
Impressions : 1180
Novo invests US$ 4.1 bn to boost Wegovy, Ozempic supply; Verona’s COPD therapy bags FDA nod
This week saw a couple of developments in the lucrative US market for glucagon-like peptide-1 (GLP-1) drugs that treat diabetes...
Impressions : 1408
FDA raises cGMP concerns at Lupin’s US, India units; Sanofi begins hunt for new CEO
This week, Phispers brings you news about the CEOs of Sandoz and Sanofi.
While Richard Francis, CEO of Novartis’ generi...
Impressions : 4163

